Atlas Trials

Phase I Study of Gemcitabine or S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer

Clinical trial NCT01291615 · COMPLETED

Trial details

NCT number
NCT01291615
Sponsor
Kansai Hepatobiliary Oncology Group
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Biliary Tract Cancer
Start date
2010-12-01
Primary completion
2012-10-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.